Transaction · 0001878313-26-000008

CHAOUKI STEVEN M

CHAOUKI STEVEN M, DIR, reported a transaction classified as grant at MAIA Biotechnology, Inc. involving 24633.000000 shares for an estimated $0.00. Reported holdings after the transaction were 24633.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
MAIAMAIA Biotechnology, Inc.
Filing timeJan 05
Trade dateDec 31, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$1.60
Pre-filing
1mo ago -25.0%1w ago -25.0%1d ago -25.0%
Returns since
7d +0.0%30d +21.3%90d -16.3%180d -9.4%1y -18.8%

MAIA price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
MAIA since 2026-01-05Filed 242 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001878313-26-000008
Options
Transaction date
Dec 31, 2025
Filed Jan 05, 2026, 01:36 PM · 5d delay
Shares
24.6k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
24.6k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-10score
Filing-only score

-10

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The stock options, granted on December 31, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the…

Original filing · 0001878313-26-000008
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

MAIA